Social Media Influencers Driving Unofficial Trade for Unapproved Weight-Loss Drug

A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could result in users injecting substances of unknown origin.

Several professionals stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.

Service Reaction and Content Removal

According to TikTok, the service has removed problematic material and banned related keywords and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Research also found communities with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, glowing testimonials and detailed guides for mixing or injecting at residence.

After minutes of joining one community, a seller posted contact information, where most transactions take place. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, posts show black plastic packages with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Even if the science behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to possibly significant medical dangers”.

Manuel George
Manuel George

A UK-based tech journalist specializing in AI ethics and startup ecosystems, with over a decade of industry experience.